Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation

Autor: Marilou Shagan, Avishai Shemesh, Ayelet Filiba, Itay Moshkovits, Shirin Elhaik Goldman, Ron N. Apte, Ariel Munitz, Elena Vronov, Ron Dagan, Danielle Karo-Atar, Angel Porgador, Yaffa Mizrachi Nebenzahl, D aniel Benharroch, Yevgeny Tsirulsky
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Chemokine
Physiology
animal diseases
lcsh:Medicine
NK cells
Immunoglobulin E
Pathology and Laboratory Medicine
Mice
Immunologic Adjuvants
0302 clinical medicine
Immune Physiology
Cellular types
Medicine and Health Sciences
CCL17
Antigens
Ly

Public and Occupational Health
lcsh:Science
Lung
Immune Response
Innate Immune System
Multidisciplinary
biology
medicine.diagnostic_test
Chemotaxis
Immune cells
Animal Models
respiratory system
Vaccination and Immunization
Cell Motility
Cytokines
White blood cells
Tumor necrosis factor alpha
medicine.symptom
Chemokines
Research Article
Cell biology
Blood cells
Immunology
Inflammation
Mice
Transgenic

Mouse Models
chemical and pharmacologic phenomena
Research and Analysis Methods
Peripheral blood mononuclear cell
03 medical and health sciences
Th2 Cells
Signs and Symptoms
Model Organisms
Diagnostic Medicine
medicine
Animals
Natural Cytotoxicity Triggering Receptor 1
Macrophages
lcsh:R
Biology and Life Sciences
Molecular Development
biochemical phenomena
metabolism
and nutrition

Asthma
Eosinophils
030104 developmental biology
Bronchoalveolar lavage
Gene Expression Regulation
Animal cells
Immune System
biology.protein
bacteria
lcsh:Q
Preventive Medicine
CCL24
030215 immunology
Developmental Biology
Zdroj: PLoS ONE, Vol 11, Iss 8, p e0160779 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: The function of NCR1 was studied in a model of experimental asthma, classified as a type 1 hypersensitivity reaction, in mice. IgE levels were significantly increased in the serum of OVA immunized NCR1 deficient (NCR1gfp/gfp) mice in comparison to OVA immunized wild type (NCR1+/+) and adjuvant immunized mice. Histological analysis of OVA immunized NCR1gfp/gfp mice revealed no preservation of the lung structure and overwhelming peribronchial and perivascular granulocytes together with mononuclear cells infiltration. OVA immunized NCR+/+ mice demonstrated preserved lung structure and peribronchial and perivascular immune cell infiltration to a lower extent than that in NCR1gfp/gfp mice. Adjuvant immunized mice demonstrated lung structure preservation and no immune cell infiltration. OVA immunization caused an increase in PAS production independently of NCR1 presence. Bronchoalveolar lavage (BAL) revealed NCR1 dependent decreased percentages of eosinophils and increased percentages of lymphocytes and macrophages following OVA immunization. In the OVA immunized NCR1gfp/gfp mice the protein levels of eosinophils’ (CCL24) and Th2 CD4+ T-cells’ chemoattractants (CCL17, and CCL24) in the BAL are increased in comparison with OVA immunized NCR+/+ mice. In the presence of NCR1, OVA immunization caused an increase in NK cells numbers and decreased NCR1 ligand expression on CD11c+GR1+ cells and decreased NCR1 mRNA expression in the BAL. OVA immunization resulted in significantly increased IL-13, IL-4 and CCL17 mRNA expression in NCR1+/+ and NCR1gfp/gfp mice. IL-17 and TNFα expression increased only in OVA-immunized NCR1+/+mice. IL-6 mRNA increased only in OVA immunized NCR1gfp/gfp mice. Collectively, it is demonstrated that NCR1 dampens allergic eosinophilic airway inflammation.
Databáze: OpenAIRE